Weight-loss medicines do not remove the need for broader health care. Doctors interviewed by KFF Health News said people taking GLP-1 drugs still benefit from movement, nutritious food, sleep, mental health support and close attention to the dose their clinician prescribed.
The report follows Jelon Smart, a 48-year-old caterer in Savannah, Georgia, who started Ozempic after severe ankle pain and an Achilles tendinitis diagnosis. She said she initially lost 30 pounds without changing her habits, then reached a plateau. After adding an intensive gym routine, she reported going from 285 to 175 pounds and said her ankle pain and swelling resolved.
Smart's result is one person's experience, not a forecast for every patient. The article does not establish which share of her change came from medication, exercise, time or other factors. It shows why clinicians look beyond a scale reading, but it is not a controlled comparison of treatment strategies.
Movement and Food Quality Remain Part of Care
Obesity medicine physician Dafina Allen told KFF Health News that eating less while taking a GLP-1 does not by itself guarantee better health. She pointed to exercise and food quality as parts of a sustainable plan, alongside familiar measures such as adequate sleep.
The report does not prescribe one workout or meal pattern. A person's mobility, medical history, nutritional needs and treatment goals can change what is safe and realistic. Advice should therefore be individualized rather than converted into a test of willpower.
That distinction also matters when weight loss slows. KFF's report notes that hormones, metabolism and genetics affect the path, while Smart's account describes a plateau. It does not prove that every plateau has one mechanism or that more exercise will always restart weight loss.
Mental Health and Dose Monitoring Are Not Extras
Allen said weight loss may not resolve distress about food or body image. Internist Gerald Onuoha recommended speaking with a family member or licensed professional when support is needed. Their comments place mental health inside treatment rather than treating it as a reward that automatically arrives with a lower weight.
Onuoha also warned against increasing a GLP-1 dose too quickly or departing from the recommended schedule. He told KFF Health News that he had seen hospital patients with pancreatitis, gallstones or acute kidney injury and asks how long they have taken the medicine and whether they followed directions.
Those observations are a reason for clinical monitoring, not proof that every reported complication was caused by a GLP-1. People should discuss dosing and adverse symptoms with a qualified clinician; an online article cannot determine an individual's dose or whether a medicine is appropriate.
A Separate Study Examined Eating Routines
A 2026 Health Psychology study analyzed food logs from 112 adults in a remote behavioral weight-loss program. During the first 12 weeks, participants recorded food in an app and weighed themselves on a study-provided wireless scale. The analysis examined day-to-day calorie stability and how often foods were repeated.
Participants whose logged foods were mostly repeats lost an average of 5.9% of body weight, compared with 4.3% among those whose entries were mostly unique. Greater daily calorie stability was also associated with more weight loss. For each additional 100 calories of average daily fluctuation, expected weight loss was 0.6 percentage points lower in the model.
The study did not assign people to repetitive or varied diets. Thirty-three of 145 enrolled participants were excluded because they logged food on fewer than 75% of study days, and the final sample was 84.8% women with an average age of 52.6. Tracking accuracy, motivation and other unmeasured differences could help explain the associations.
Most importantly for this article, the study was not a trial of meal repetition in GLP-1 users. It cannot show that repeating meals breaks a medication plateau, and the authors said experimental research is needed before cause and effect can be established.
Support Should Replace Moral Judgment
The hard boundary is simple: medication is not a shortcut that cancels care, and needing medication is not a moral failure. The KFF interviews support integrated care around movement, nutrition, mental health and dosing. The routine-eating analysis suggests a possible behavioral tool, with clear limits.
Combining those sources responsibly means keeping their evidence separate. One patient story can illustrate a plateau, and one observational study can identify an association. Neither justifies rigid meal rules, invented policy fixes or language that reduces patients to discipline. The clinical task is to build a plan a person can follow safely, monitor it and change it when the evidence or the patient's needs demand that.